Core Viewpoint - The company claims to serve over 95% of domestic ADC companies, highlighting its strong competitive advantage in the ADC small molecule sector and significant engagement in the ADC market [1] Group 1: Company Performance - As of 2024, the company has facilitated $28 billion in XDC overseas transactions, with 27 transactions completed [1] - The company has serviced over 95% of the 22 domestic ADC companies that have engaged in overseas transactions [1] - The company has taken on over 110 ADC projects in 2024, with nearly 1,000 active clients [1] Group 2: Intellectual Property and Regulatory Achievements - The company has applied for 12 domestic invention patents and 2 international invention patents related to ADC as of March 31, 2025 [1] - The company has completed the filing of 13 small molecule products related to ADC with the FDA DMF in the United States [1]